Table 2.
Proposed secondary outcomes in dialysis catheter trials
| Catheter dysfunction |
| Use of thrombolytic therapy |
| Antimicrobial resistance—not just of clinical isolates but also of surveillance cultures |
| Catheter removal |
| All-cause hospitalization or hospitalization due to infection |
| Systemic antimicrobial use/exposure |
| Death |
| Any adverse events directly related to the drug on the patient or catheter integrity |
| Cost of care |
| Quality of life |